Molecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma.
- Author:
Neung Hwa PARK
1
;
Il Han SONG
;
Young Hwa CHUNG
Author Information
1. Division of Gastroenterology, Department of Internal Medicine, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan, Korea.
- Publication Type:Review
- Keywords:
Hepatocellular carcinoma;
Hepatitis B virus;
Hepatitis B x protein (HBx);
Transactivator
- MeSH:
Carcinoma, Hepatocellular*;
Cell Proliferation;
Cytokines;
DNA;
Fibrosis;
Hepatitis B virus;
Hepatitis B, Chronic;
Inflammation;
Liver;
Trans-Activators
- From:Gut and Liver
2007;1(2):101-117
- CountryRepublic of Korea
- Language:English
-
Abstract:
Hepatocellular carcinoma (HCC) is one of the most frequent and malignant diseases worldwide. Epidemiological studies have clearly demonstrated that chronic hepatitis B virus (HBV) infection is a major etiological factor in the development of HCC. The pathogenesis of HBV-associated HCC has been studied extensively, and the molecular changes associated with malignant transformation have been identified. The predominant carcinogenic mechanisms of HBV-associated HCC are chronic inflammation and the effects of cytokines in the development of fibrosis and liver cell proliferation. An important role is also played by the integration of HBV DNA into host cellular DNA, which disrupts or promotes the expression of cellular genes that are important in cell growth and differentiation. Especially, HBx protein is a transactivating protein that promotes cell growth, survival, and the development of HCC. Continued investigation of the mechanisms underlying hepatocarcinogenesis will refine our current understanding of the molecular and cellular basis for neoplastic transformation in the liver. Prevention of HBV infections and effective treatments for chronic hepatitis B are still needed for the global control of HBV-associated HCC. This review summarizes the current knowledge on the mechanisms involved in HBV-associated hepatocarcinogenesis.
